DISCUSSION
AD is a chronic relapsing skin disease of complex etiology, characterized by an erythematous and pruritic rash that often affects children.AD prevalence is between 5 and 20% (4).AD is usually associated with a high serum total IgE level and a personal or family history of atopy that includes a group of diseases such as eczema, asthma, and allergic rhinitis. EH, also known as Kaposi’s varicelliform eruption, is a rare complication that occurs in less than 3% of patients with atopic dermatitis. The most common causes of EH are herpes simplex virus (HSV) type 1 and type 2.it has also been shown that coxsackie virus A16 and vaccinia virus play a role in the pathogenesis of EH (5).EH may spread to disseminated or fatal course with visceral involvement in some patients.The mortality rate is between 1 and 9% (6).Severe eczema, high serum total IgE levels, a history of food allergy or asthma appear to be predisposing factors (7).Although the disease can be seen clinically wherever there is epithelial barrier damage in the body, it is most commonly located in the face and neck region. The presence of common worms with a diameter of 2-3 mm is a clue for diagnosis.Fever and regional lymphadenopathies may accompany the lesions (8).Similar to the literature, common worms on the face were observed in our patient, but no fever or lymphadenopathy was observed.Electron microscopy, viral culture and PCR can be used for diagnosis.In the differential diagnosis, allergic contact dermatitis, impetigo and histiocytosis, especially varicella zoster, should be considered(9).In the treatment of EH, systemic antiviral and antibacterial therapy should be planned in addition to topical antiviral and antibacterial therapy, depending on the extent of the lesion (10).In our patient, oral amoxicillin + clavulanic acid and acyclovir and topical acyclovir treatment were given due to the widespread involvement in the face area. The lesions were completely controlled within a month.There is no data in the literature on EH after AIT.Since there is no data on eczema herpeticum after AIT in the literature, we wanted to share a very rare case.
REFERANCES
1. Noon L. Prophylactic inoculation against hay fever. Lancet 1911;1:1572-3.
2.. Freeman J. Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet 1911;2:814- 7
3.Damour A, Garcia M, Seneschal J, Lévêque N, Bodet C. Eczema Herpeticum: Clinical and Pathophysiological Aspects. Clin Rev Allergy Immunol. 2020 Aug;59(1):1-18. doi: 10.1007/s12016-019-08768-3. PMID: 31836943.
4.SpergelJM.From atopic dermatitis to asthma:the atopic march .Ann Allergy Asthma Immunol 2010; 105:99.
5.12.Mackley CL, Adams DR, Anderson B, Miller JJ. Eczema herpeticum: a dermatologic emergency. Dermatol Nurs 2002;14(5):307-10
6.11.Olson J, Robles DT, Kirby P, Colven R. Kaposi varicelli- form eruption (eczema herpeticum). Dermatol Online J 2008;14(2):18.
7.LeungDY.Why is eczema herpeticum unexpectedly rare? AntiviralRes2013;98:153.
8.Peng WM, Jenneck C, Bussmann C, et al. Risk factors of atopic dermatitis patients for eczema herpeticum. J Invest Dermatol 2007;127(5):1261-3.
9.Şenel E.Eczema Herpeticum: A case report. Dicle medical journal.2011; 38 (3): 342-344
10.Kimata H. Rapidly increasing incidence of Kaposi’s varicel- liform eruption in patients with atopic dermatitis. Indian J Dermatol Venereol Leprol 2008;74(3):260-1